Search Results
Slidesets
Dolutegravir Plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV Post-Exposure Prophylaxis: Efficacy and Safety Results from Real World Study - Chongxi Li
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Abstracts
Sero-prevalence of human immunodeficiency virus and Syphilis among pregnant women attending antenatal clinics in Tanzania: results from ANC sentinel surveillance 2018
P. Urasa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
The costs of community based HIV self-test (HIV-ST) kit distribution: results from three (3) district sites in Zimbabwe- C. Mangenah
Presented at:
INTEREST 2017
Abstracts
What are the drivers of improved viral suppression among HIV infected children (0-14 years)? Results from the national data warehouse in Kenya 2020
I. Mutisya
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Early antiretroviral therapy exposure associated risk of developmental disorder by school-aged and adolescent years among HIV-exposed uninfected children from Uganda
J. Awadu
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Slidesets
Oral Abstract #9 - Predicting Cognitive Frailty in People Aging with HIV, Insights from the Positive Brain Health Now Study - Henry Michael.pdf
Presented at:
International Workshop on Aging & HIV 2024
Abstracts
Factors associated with poor adherence among non-virological suppressing School going adolescents: lessons from The Aids Support Organization (TASO) in Masaka, Uganda
G. Jjuuko
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Treatment outcomes of HIV infected children, adolescents and young adults failing second line antiretroviral treatment at Newlands Clinic, Zimbabwe from 2014-2019
T. Kufa
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
In Urban settings, Vertically-Infected Adolescents Experience Treatment Failure driven by HIV Drug Resistance Emergence: Results from a Follow-up Analysis in Cameroon
D. Njume
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019
K. Brooks
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021